Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Diran Dancheng Pharmaceutical is a Chinese pharmaceutical manufacturing company and a core subsidiary of the Shanghai Diran Pharmaceutical Group. Located in Dancheng County, Henan Province, the company specializes in the production of chemical active pharmaceutical ingredients (APIs) and finished oral solid dosage forms. Its product portfolio primarily focuses on chronic disease management, featuring widely used treatments for type 2 diabetes, cardiovascular conditions, and bacterial infections. The facility is GMP-certified and serves as a significant production base for the group's domestic supply chain. The company maintains a strong presence in the generic drug market, providing affordable essential medicines across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 上海迪冉郸城制药.